M&T Bank’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

M&T Bank’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,570	Closed	-$12.9K	–	1768
2022 Q4	$12.9K	Hold	14,570	–	–	﹤0.01%	1590
2022 Q3	$23K	Hold	14,570	–	–	﹤0.01%	1555
2022 Q2	$7K	Buy	+14,570	New	+$25.2K	﹤0.01%	1567
2016 Q2	–	Sell	-18,000	Closed	-$97K	–	1789
2016 Q1	$97K	Hold	18,000	–	–	﹤0.01%	1563
2015 Q4	$157K	Buy	+18,000	New	+$152K	﹤0.01%	1542
2015 Q3	–	Sell	-11,000	Closed	-$194K	–	2061
2015 Q2	$194K	Buy	+11,000	New	+$141K	﹤0.01%	1789

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

M&T Bank's SRNE Position: Q1 2023 in Review

M&T Bank sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 14,570 shares — an estimated $12.9K sold.

M&T Bank first reported a position in SRNE in Q2 2015 and held it in 6 quarters. The position peaked at $194K in Q2 2015. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

M&T Bank reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
M&T Bank sold 14,570 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $12.9K.
M&T Bank first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and held it in 6 quarters.
M&T Bank's Sorrento Therapeutics, Inc. position peaked at $194K in Q2 2015.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on M&T Bank's 13F filing for Q1 2023, filed 11 May 2023.